Skip to main content
logo
Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.1651
+0.0051 (3.19%)
At close: Sep 16, 2026, 4:00 PM EDT
0.1594
-0.0057 (-3.45%)
Pre-market: Sep 17, 2026, 8:50 AM EDT

MTNB Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.13.190.03
Revenue Growth
----65.62%9560.61%-79.16%
Gross Profit
--0.09-11.43-13.39-13.49-14.55
Operating Income
-6.67-6.96-20.16-23.77-24.59-24.74
Net Income
-7.31-10.96-24.25-22.94-21-23.68
Earnings Per Share
-1.19-2.00-4.98-5.28-4.84-5.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.7647.2813.7628.7649.62
Total Debt
0.011.352.893.564.124.7
Net Cash (Debt)
0.762.654.3910.224.6444.92
Net Cash Growth
-81.10%-39.75%-56.96%-58.60%-45.15%-18.22%
Net Cash Per Share
0.120.480.902.355.6810.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.42-7.01-15.89-15.28-19.16-15.22
Capital Expenditures
----0.22-0.89-0.26
Free Cash Flow
-6.42-7.01-15.89-15.5-20.05-15.48
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
----2168.43%-771.33%-74954.54%
Pretax Margin
----2093.25%-658.63%-70554.55%
Profit Margin
----2093.25%-658.63%-71754.54%
FCF Margin
----1413.87%-628.86%-46918.18%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---42.8634.016618.48